{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T22:10:33Z","timestamp":1740262233351,"version":"3.37.3"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,22]]},"DOI":"10.7759\/cureus.79468","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T21:33:51Z","timestamp":1740260031000},"source":"Crossref","is-referenced-by-count":0,"title":["An Unusual Therapy for an Atypical Case of Secondary Extranodal, Non-parenchymal Central Nervous System Marginal Zone Lymphoma"],"prefix":"10.7759","author":[{"given":"Siham","family":"Ahchouch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelilah","family":"El Barrichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Allaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hicham","family":"El Maaroufi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Doghmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000926","article-title":"Treatment strategies and prognostic factors in secondary central nervous system lymphoma: a multicenter study of 124 patients","volume":"7","author":"Treiber H","year":"2023","unstructured":"Treiber H, Nilius-Eliliwi V, Seifert N, et al.. Treatment strategies and prognostic factors in secondary central nervous system lymphoma: a multicenter study of 124 patients. Hemasphere. 2023, 7:e926. 10.1097\/HS9.0000000000000926","journal-title":"Hemasphere"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19064","article-title":"Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology Guideline","volume":"204","author":"Walewska R","year":"2024","unstructured":"Walewska R, Eyre TA, Barrington S, et al.. Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology Guideline. Br J Haematol. 2024, 204:86-107. 10.1111\/bjh.19064","journal-title":"Br J Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000936","article-title":"Central nervous system lymphomas","volume":"26","author":"Grommes C","year":"2020","unstructured":"Grommes C. Central nervous system lymphomas. Continuum (Minneap Minn). 2020, 26:1476-94. 10.1212\/CON.0000000000000936","journal-title":"Continuum (Minneap Minn)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.72.7602","article-title":"Primary CNS lymphoma","volume":"35","author":"Grommes C","year":"2017","unstructured":"Grommes C, DeAngelis LM. Primary CNS lymphoma. J Clin Oncol. 2017, 35:2410-8. 10.1200\/JCO.2017.72.7602","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008377","article-title":"Primary central nervous system lymphoma","volume":"140","author":"Schaff LR","year":"2022","unstructured":"Schaff LR, Grommes C. Primary central nervous system lymphoma. Blood. 2022, 140:971-9. 10.1182\/blood.2020008377","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281457","article-title":"Prevention and management of secondary central nervous system lymphoma","volume":"108","author":"Bobillo S","year":"2023","unstructured":"Bobillo S, Khwaja J, Ferreri AJ, Cwynarski K. Prevention and management of secondary central nervous system lymphoma. Haematologica. 2023, 108:673-89. 10.3324\/haematol.2022.281457","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18539. Epub 2022 Nov 21.","article-title":"Management of secondary central nervous system lymphoma","volume":"200","author":"Cwynarski K","year":"2023","unstructured":"Cwynarski K, Cummin T, Osborne W, et al.. Management of secondary central nervous system lymphoma. Br J Haematol. 2023, 200:160-9. 10.1111\/bjh.18539. Epub 2022 Nov 21.","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014506","article-title":"Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients","volume":"139","author":"Wilson MR","year":"2022","unstructured":"Wilson MR, Eyre TA, Kirkwood AA, et al.. Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients. Blood. 2022, 139:2499-511. 10.1182\/blood.2021014506","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006926","article-title":"Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers","volume":"137","author":"Evens AM","year":"2021","unstructured":"Evens AM, Danilov A, Jagadeesh D, et al.. Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers. Blood. 2021, 137:374-86. 10.1182\/blood.2020006926","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14387","article-title":"Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients","volume":"176","author":"Wanquet A","year":"2017","unstructured":"Wanquet A, Birsen R, Bonnet C, et al.. Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients. Br J Haematol. 2017, 176:37-49. 10.1111\/bjh.14387","journal-title":"Br J Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113436","article-title":"A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma","volume":"196","author":"Habringer S","year":"2024","unstructured":"Habringer S, Demel UM, Fietz AK, et al.. A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma. Eur J Cancer. 2024, 196:113436. 10.1016\/j.ejca.2023.113436","journal-title":"Eur J Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.136556","article-title":"Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia","volume":"101","author":"Strati P","year":"2016","unstructured":"Strati P, Uhm JH, Kaufmann TJ, et al.. Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia. Haematologica. 2016, 101:458-65. 10.3324\/haematol.2015.136556","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2732","article-title":"An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement","volume":"9","author":"Sunderland AJ","year":"2020","unstructured":"Sunderland AJ, Steiner RE, Al Zahrani M, et al.. An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement. Cancer Med. 2020, 9:663-70. 10.1002\/cam4.2732","journal-title":"Cancer Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12730","article-title":"Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site","volume":"165","author":"Khalil MO","year":"2014","unstructured":"Khalil MO, Morton LM, Devesa SS, Check DP, Curtis RE, Weisenburger DD, Dores GM. Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site. Br J Haematol. 2014, 165:67-77. 10.1111\/bjh.12730","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19238","article-title":"Primary central nervous system marginal zone lymphoma","volume":"204","author":"Flospergher E","year":"2024","unstructured":"Flospergher E, Marino F, Calimeri T, Cangi MG, Ferreri AJ, Ponzoni M, Bongiovanni L. Primary central nervous system marginal zone lymphoma. Br J Haematol. 2024, 204:31-44. 10.1111\/bjh.19238","journal-title":"Br J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1791849","article-title":"Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement","volume":"61","author":"Furqan F","year":"2020","unstructured":"Furqan F, Watson G, Samaniego F, et al.. Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement. Leuk Lymphoma. 2020, 61:2980-4. 10.1080\/10428194.2020.1791849","journal-title":"Leuk Lymphoma"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2008.n.043","article-title":"Primary central nervous system marginal zone B-cell lymphoma of the Basal Ganglia mimicking low-grade glioma: a case report and review of the literature","volume":"8","author":"Park I","year":"2008","unstructured":"Park I, Huh J, Kim JH, Lee SW, Ryu MH, Kang YK. Primary central nervous system marginal zone B-cell lymphoma of the Basal Ganglia mimicking low-grade glioma: a case report and review of the literature. Clin Lymphoma Myeloma. 2008, 8:305-8. 10.3816\/CLM.2008.n.043","journal-title":"Clin Lymphoma Myeloma"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-018-0687-9","article-title":"Marginal zone lymphoma: clinicopathologic variations and approaches to therapy","volume":"20","author":"Ayyappan S","year":"2018","unstructured":"Ayyappan S, William BM. Marginal zone lymphoma: clinicopathologic variations and approaches to therapy. Curr Oncol Rep. 2018, 20:33. 10.1007\/s11912-018-0687-9","journal-title":"Curr Oncol Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-0976-3","article-title":"Central nervous system manifestations of marginal zone B-cell lymphoma","volume":"89","author":"Bayraktar S","year":"2010","unstructured":"Bayraktar S, Stefanovic A, Montague N, Davis J, Murray T, Lossos IS. Central nervous system manifestations of marginal zone B-cell lymphoma. Ann Hematol. 2010, 89:1003-9. 10.1007\/s00277-010-0976-3","journal-title":"Ann Hematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.06.009","article-title":"Survival of secondary central nervous system lymphoma patients in the rituximab era","volume":"16","author":"Herr MM","year":"2016","unstructured":"Herr MM, Mohile NA, Barr PM, van Wijngaarden E, Brown EB, Rich DQ. Survival of secondary central nervous system lymphoma patients in the rituximab era. Clin Lymphoma Myeloma Leuk. 2016, 16:e123-7. 10.1016\/j.clml.2016.06.009","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-0496","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue","volume":"101","author":"Zucca E","year":"2003","unstructured":"Zucca E, Conconi A, Pedrinis E, et al.. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003, 101:2489-95. 10.1158\/1078-0432.CCR-14-0496","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.09.012","article-title":"Extranodal marginal zone lymphoma of the central nervous system","volume":"18","author":"Ayanambakkam A","year":"2018","unstructured":"Ayanambakkam A, Ibrahimi S, Bilal K, Cherry MA. Extranodal marginal zone lymphoma of the central nervous system. Clin Lymphoma Myeloma Leuk. 2018, 18:34-7.e8. 10.1016\/j.clml.2017.09.012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2571","article-title":"Central nervous system involvement in primary bone marrow or splenic marginal zone lymphoma: Report of two cases and review of the literature","volume":"37","author":"Angelopoulou MK","year":"2019","unstructured":"Angelopoulou MK, Vassilakopoulos TP, Konstantinou E, et al.. Central nervous system involvement in primary bone marrow or splenic marginal zone lymphoma: Report of two cases and review of the literature. Hematol Oncol. 2019, 37:219-22. 10.1002\/hon.2571","journal-title":"Hematol Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.E0501","article-title":"Meningeal lymphomatosis as the first manifestation of splenic marginal zone lymphoma","volume":"82","author":"Bruna J","year":"2005","unstructured":"Bruna J, Mart\u00ednez-Yelamos S, Alonso E, et al.. Meningeal lymphomatosis as the first manifestation of splenic marginal zone lymphoma. Int J Hematol. 2005, 82:63-5. 10.1532\/IJH97.E0501","journal-title":"Int J Hematol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-020-01608-6","article-title":"Leptomeningeal metastasis in a marginal zone lymphoma, presenting as a delirium: case report","volume":"20","author":"Dreessen L","year":"2020","unstructured":"Dreessen L, Mar\u00e9chal N, Verheyden M, et al.. Leptomeningeal metastasis in a marginal zone lymphoma, presenting as a delirium: case report. BMC Geriatr. 2020, 20:213. 10.1186\/s12877-020-01608-6","journal-title":"BMC Geriatr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4081\/hr.2010.e10","article-title":"Dural MALT lymphoma with disseminated disease","volume":"2","author":"Matmati K","year":"2010","unstructured":"Matmati K, Matmati N, Hannun YA, et al.. Dural MALT lymphoma with disseminated disease. Hematol Rep. 2010, 2:e10. 10.4081\/hr.2010.e10","journal-title":"Hematol Rep"},{"key":"ref27","article-title":"Marginal zone lymphoma with central nervous system spread - a case report","volume":"1","author":"Cabot JSF","year":"2014","unstructured":"Cabot JSF, Paramasivam NK, Menon P. Marginal zone lymphoma with central nervous system spread - a case report. Int J Clin Med\r\n. 2014, 1:31-4.","journal-title":"Int J Clin Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/2162-3619-1-32","article-title":"Treatment of splenic marginal zone lymphoma of the CNS with high-dose therapy and allogeneic stem cell transplantation","volume":"1","author":"Busemann C","year":"2012","unstructured":"Busemann C, Gudzuhn A, Hirt C, et al.. Treatment of splenic marginal zone lymphoma of the CNS with high-dose therapy and allogeneic stem cell transplantation. Exp Hematol Oncol. 2012, 1:32. 10.1186\/2162-3619-1-32","journal-title":"Exp Hematol Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-006-0761-1","article-title":"Intracranial non-Hodgkin's MALT lymphoma mimicking a large convexity meningioma","volume":"148","author":"Pavlou G","year":"2006","unstructured":"Pavlou G, Pal D, Bucur S, Chakrabarty A, van Hille PT. Intracranial non-Hodgkin's MALT lymphoma mimicking a large convexity meningioma. Acta Neurochir (Wien). 2006, 148:791-3; discussion 793. 10.1007\/s00701-006-0761-1","journal-title":"Acta Neurochir (Wien)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290026411","article-title":"Leptomeningeal involvement in a patient with splenic lymphoma with villous lymphocytes","volume":"43","author":"Gotlib V","year":"2002","unstructured":"Gotlib V, Singareddy S, Gergis U, et al.. Leptomeningeal involvement in a patient with splenic lymphoma with villous lymphocytes. Leuk Lymphoma. 2002, 43:1337-40. 10.1080\/10428190290026411","journal-title":"Leuk Lymphoma"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940701)74:1<61::aid-cncr2820740111>3.0.co;2-f","article-title":"Leukemic meningitis in a patient with splenic lymphoma with villous lymphocytes (SLVL). Meningitis as a possible initial manifestation of SLVL","volume":"74","author":"Yamazaki K","year":"1994","unstructured":"Yamazaki K, Shimizu S, Negami T, et al.. Leukemic meningitis in a patient with splenic lymphoma with villous lymphocytes (SLVL). Meningitis as a possible initial manifestation of SLVL. Cancer. 1994, 74:61-5. 10.1002\/1097-0142(19940701)74:1&lt;61::aid-cncr2820740111&gt;3.0.co;2-f","journal-title":"Cancer"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3171\/foc.2006.21.5.6","article-title":"Primary dural lymphomas: a review","volume":"21","author":"Iwamoto FM","year":"2006","unstructured":"Iwamoto FM, Abrey LE. Primary dural lymphomas: a review. Neurosurg Focus. 2006, 21:E5. 10.3171\/foc.2006.21.5.6","journal-title":"Neurosurg Focus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03422-x","article-title":"Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis","volume":"147","author":"Shin DW","year":"2020","unstructured":"Shin DW, Kim JH, Kim YH, Cho YH, Hong SH. Primary central nervous system lymphoma involving the hypothalamic-pituitary axis: a case series and pooled analysis. J Neurooncol. 2020, 147:339-49. 10.1007\/s11060-020-03422-x","journal-title":"J Neurooncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109097736","article-title":"Extranodal marginal zone B-cell lymphoma of malt type involving the cavernous sinus","volume":"42","author":"Sanjeevi A","year":"2001","unstructured":"Sanjeevi A, Krishnan J, Bailey PR, Catlett J. Extranodal marginal zone B-cell lymphoma of malt type involving the cavernous sinus. Leuk Lymphoma. 2001, 42:1133-7. 10.3109\/10428190109097736","journal-title":"Leuk Lymphoma"},{"key":"ref35","article-title":"Mucosa-associated lymphoid tissue lymphoma of the pituitary gland: MR imaging features","volume":"23","author":"Lee JH","year":"2002","unstructured":"Lee JH, Lee HK, Choi CT, et al.. Mucosa-associated lymphoid tissue lymphoma of the pituitary gland: MR imaging features. Am J Neuroradiol. 2002, 23:838-40.","journal-title":"Am J Neuroradiol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/hed.10311","article-title":"Management of neurotropic low-grade B-cell lymphoma: report of two cases","volume":"25","author":"Garcia-Serra A","year":"2003","unstructured":"Garcia-Serra A, Price Mendenhall N, Hinerman RW, Lynch JW Jr, Braylan RC, Mancuso AA. Management of neurotropic low-grade B-cell lymphoma: report of two cases. Head Neck. 2003, 25:972-6. 10.1002\/hed.10311","journal-title":"Head Neck"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1218006","article-title":"Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences","volume":"58","author":"de la Fuente MI","year":"2017","unstructured":"de la Fuente MI, Haggiagi A, Moul A, et al.. Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences. Leuk Lymphoma. 2017, 58:882-8. 10.1080\/10428194.2016.1218006","journal-title":"Leuk Lymphoma"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.052","article-title":"Primary central nervous system mucosa-associated lymphoid tissue lymphoma: case report and literature review","volume":"9","author":"Razaq W","year":"2009","unstructured":"Razaq W, Goel A, Amin A, Grossbard ML. Primary central nervous system mucosa-associated lymphoid tissue lymphoma: case report and literature review. Clin Lymphoma Myeloma. 2009, 9:E5-9. 10.3816\/CLM.2009.n.052","journal-title":"Clin Lymphoma Myeloma"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-021-00556-w","article-title":"Primary marginal zone B-cell lymphoma of the cavernous sinus: a case report and review of the literature","volume":"21","author":"Yang CC","year":"2021","unstructured":"Yang CC, Chen TY, Tsui YK, Ko CC. Primary marginal zone B-cell lymphoma of the cavernous sinus: a case report and review of the literature. BMC Med Imaging. 2021, 21:25. 10.1186\/s12880-021-00556-w","journal-title":"BMC Med Imaging"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1731064","article-title":"Marginal zone B-cell lymphoma of the gasserian ganglion: case report and review of the literature","author":"Hegazy A","year":"2022","unstructured":"Hegazy A, Al-Shami H, Arundhata B, et al.. Marginal zone B-cell lymphoma of the gasserian ganglion: case report and review of the literature. Brazilian Neurosurgery-Arquivos Brasileiros De Neurocirurgia. 2022, 10.1055\/s-0041-1731064","journal-title":"Brazilian Neurosurgery-Arquivos Brasileiros De Neurocirurgia"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2009.10.001","article-title":"Intracranial mucosa-associated lymphoid tissue (MALT) lymphoma","volume":"17","author":"Ferguson SD","year":"2010","unstructured":"Ferguson SD, Musleh W, Gurbuxani S, Shafizadeh SF, Lesniak MS. Intracranial mucosa-associated lymphoid tissue (MALT) lymphoma. J Clin Neurosci. 2010, 17:666-9. 10.1016\/j.jocn.2009.10.001","journal-title":"J Clin Neurosci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199701000-00009","article-title":"Primary low-grade B-cell lymphoma of the dura: a mucosa associated lymphoid tissue-type lymphoma","volume":"21","author":"Kumar S","year":"1997","unstructured":"Kumar S, Kumar D, Kaldjian EP, Bauserman S, Raffeld M, Jaffe ES. Primary low-grade B-cell lymphoma of the dura: a mucosa associated lymphoid tissue-type lymphoma. Am J Surg Pathol. 1997, 21:81-7. 10.1097\/00000478-199701000-00009","journal-title":"Am J Surg Pathol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082420","article-title":"Clinical outcomes of severe rhinosinusitis complicated with cavernous sinus syndrome","volume":"13","author":"Lin JY","year":"2024","unstructured":"Lin JY, Liu CL, Dai ZY, et al.. Clinical outcomes of severe rhinosinusitis complicated with cavernous sinus syndrome. J Clin Med. 2024, 13:2420. 10.3390\/jcm13082420","journal-title":"J Clin Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1177\/1971400917740361","article-title":"Orbital apex disorders: imaging findings and management","volume":"31","author":"Goyal P","year":"2018","unstructured":"Goyal P, Lee S, Gupta N, et al.. Orbital apex disorders: imaging findings and management. Neuroradiol J. 2018, 31:104-25. 10.1177\/1971400917740361","journal-title":"Neuroradiol J"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.129200","article-title":"Dural lesions mimicking meningiomas","volume":"33","author":"Johnson MD","year":"2002","unstructured":"Johnson MD, Powell SZ, Boyer PJ, Weil RJ, Moots PL. Dural lesions mimicking meningiomas. Hum Pathol. 2002, 33:1211-26. 10.1053\/hupa.2002.129200","journal-title":"Hum Pathol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32834","article-title":"Primary dural lymphomas: clinical presentation, management, and outcome","volume":"126","author":"Karschnia P","year":"2020","unstructured":"Karschnia P, Batchelor TT, Jordan JT, et al.. Primary dural lymphomas: clinical presentation, management, and outcome. Cancer. 2020, 126:2811-20. 10.1002\/cncr.32834","journal-title":"Cancer"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25622","article-title":"Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis","volume":"9","author":"Chihara D","year":"2018","unstructured":"Chihara D, Fowler NH, Oki Y, et al.. Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis. Oncotarget. 2018, 9:28897-902. 10.18632\/oncotarget.25622","journal-title":"Oncotarget"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.149120","article-title":"Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO)","volume":"102","author":"Pe\u00f1alver FJ","year":"2017","unstructured":"Pe\u00f1alver FJ, Sancho JM, de la Fuente A, et al.. Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO). Haematologica. 2017, 102:235-45. 10.3324\/haematol.2016.149120","journal-title":"Haematologica"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005602","article-title":"Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement","volume":"6","author":"Akin S","year":"2022","unstructured":"Akin S, Hosing C, Khouri I, et al.. Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement. Blood Adv. 2022, 6:2267-74. 10.1182\/bloodadvances.2021005602","journal-title":"Blood Adv"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.12.2462.2462","article-title":"Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients","volume":"76","author":"Kolb HJ","year":"1990","unstructured":"Kolb HJ, Mitterm\u00fcller J, Clemm C, et al.. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 1990, 76:2462-5. 10.1182\/blood.V76.12.2462.2462","journal-title":"Blood"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700918","article-title":"Chimerism analysis on mononuclear cells in the CSF after allogeneic bone marrow transplantation","volume":"20","author":"Hibi S","year":"1997","unstructured":"Hibi S, Tsunamoto K, Todo S, et al.. Chimerism analysis on mononuclear cells in the CSF after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997, 20:503-6. 10.1038\/sj.bmt.1700918","journal-title":"Bone Marrow Transplant"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909083396","article-title":"Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma","volume":"34","author":"Varadi G","year":"1999","unstructured":"Varadi G, Or R, Kapelushnik J, et al.. Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma. Leuk Lymphoma. 1999, 34:185-90. 10.3109\/10428199909083396","journal-title":"Leuk Lymphoma"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01508-3","article-title":"Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study","volume":"16","author":"Epperla N","year":"2023","unstructured":"Epperla N, Feng L, Shah NN, et al.. Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. J Hematol Oncol. 2023, 16:111. 10.1186\/s13045-023-01508-3","journal-title":"J Hematol Oncol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.003","article-title":"Allogeneic blood or marrow transplantation with nonmyeloablative conditioning and high-dose cyclophosphamide-based graft-versus-host disease prophylaxis for secondary central nervous system lymphoma","volume":"27","author":"Sterling CH","year":"2021","unstructured":"Sterling CH, Tsai H-L, Holdhoff M, et al.. Allogeneic blood or marrow transplantation with nonmyeloablative conditioning and high-dose cyclophosphamide-based graft-versus-host disease prophylaxis for secondary central nervous system lymphoma. Transplant Cell Ther. 2021, 27: 863-1. 10.1016\/j.annonc.2021.12.003","journal-title":"Transplant Cell Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/326775-an-unusual-therapy-for-an-atypical-case-of-secondary-extranodal-non-parenchymal-central-nervous-system-marginal-zone-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T21:33:54Z","timestamp":1740260034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/326775-an-unusual-therapy-for-an-atypical-case-of-secondary-extranodal-non-parenchymal-central-nervous-system-marginal-zone-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":54,"URL":"https:\/\/doi.org\/10.7759\/cureus.79468","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,22]]}}}